🇺🇸 perindopril, indapamide , amlodipine in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 2 reports (16.67%)
  2. Vomiting — 2 reports (16.67%)
  3. Abdominal Pain Upper — 1 report (8.33%)
  4. Acidosis — 1 report (8.33%)
  5. Acute Kidney Injury — 1 report (8.33%)
  6. Acute Myocardial Infarction — 1 report (8.33%)
  7. Adverse Drug Reaction — 1 report (8.33%)
  8. Blood Creatinine Increased — 1 report (8.33%)
  9. Blood Glucose Increased — 1 report (8.33%)
  10. Bradyarrhythmia — 1 report (8.33%)

Source database →

perindopril, indapamide , amlodipine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is perindopril, indapamide , amlodipine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for perindopril, indapamide , amlodipine in United States?

University of Roma La Sapienza is the originator. The local marketing authorisation holder may differ — check the official source linked above.